GH1 and Prader-Willi syndrome: PWS participants receiving treatment with GH during the childhood/adolescent (PWS-GH) period showed significant differences compared to PWS participants without treatment (PWS-NoGH) regarding the length of 2D and 4D, but no differences were found related to the 2D:4D ratio (Table 5).